Please assess the completion status of the following clinical trial:

Trial Title: Plasmapheresis for Nephrogenic Fibrosing Dermopathy (NFD)/Nephrogenic Systemic Fibrosis (NSF)

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* diagnosed with NFD/NSF following a kidney transplant~* diagnosed with NFD/NSF following a liver transplant~* NFD/NSF and who have not had a kidney or liver transplant~* diagnosed with NFD/NSF and who have not had a kidney or liver transplant

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: t

Study Arms:
- Group 1 (Type: ACTIVE_COMPARATOR): One to three 5-day course of plasma exchange (plasmapheresis)
- Group 2 (Type: ACTIVE_COMPARATOR): One to three 5-day course of plasma exchange (plasmapheresis)
- Group 3 (Type: NO_INTERVENTION): No intervention taken
- Group 4 (Type: ACTIVE_COMPARATOR): One to three 5-day course of plasma exchange (plasmapheresis)

Based on this trial design, predict the completion outcome and termination type (if applicable).